Drs Producoes/E+ via Getty Images Bioceres (NASDAQ:BIOX) 4Q24 results disappointed the market, with the stock falling close to 15% after the release (and 30% since my last Hold article on the company). The main disappointment came from flattish profitability for the year, mostly caused by a decreasing business in crop nutrition in Q4. The generalized bear market in wheat, corn, and soybeans probably helped the pessimistic mood around Bioceres. Although the company continues advancing its HB4 products (with ...